Authors: CONTRERA JF DEGEORGE JJ

Citation: Jf. Contrera et Jj. Degeorge, IN-VIVO TRANSGENIC BIOASSAYS AND ASSESSMENT OF THE CARCINOGENIC POTENTIAL OF PHARMACEUTICALS, Environmental health perspectives, 106, 1998, pp. 71-80

Authors: CONTRERA JF JACOBS AC DEGEORGE JJ

Citation: Jf. Contrera et al., CARCINOGENICITY TESTING AND THE EVALUATION OF REGULATORY REQUIREMENTSFOR PHARMACEUTICALS, Regulatory toxicology and pharmacology, 25(2), 1997, pp. 130-145

Authors: CHOUDARY J CONTRERA JF DEFELICE A DEGEORGE JJ FARRELLY JG FITZGERALD G GOHEER MA JACOBS A JORDAN A MEYERS L OSTERBERG R RESNICK C SUN CJ TEMPLE RJ

Citation: J. Choudary et al., RESPONSE TO MONRO AND MEHTA PROPOSAL FOR USE OF SINGLE-DOSE TOXICOLOGY STUDIES TO SUPPORT SINGLE-DOSE STUDIES OF NEW DRUGS IN HUMANS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 265-267

Authors: CONTRERA JF JACOBS AC PRASANNA HR MEHTA M SCHMIDT WJ DEGEORGE J

Citation: Jf. Contrera et al., SYSTEMIC EXPOSURE-BASED ALTERNATIVE TO THE MAXIMUM TOLERATED DOSE FORCARCINOGENICITY STUDIES OF HUMAN THERAPEUTICS, Journal of the American College of Toxicology, 14(1), 1995, pp. 1-10

Authors: CONTRERA JF

Citation: Jf. Contrera, EMERGING TRENDS IN NONCLINICAL SAFETY ASSESSMENT FOR THERAPEUTICS, Toxicologic pathology, 22(2), 1994, pp. 89-94

Authors: CONTRERA JF AUB D BARBEHENN E BELAIR E CHEN C EVONIUK G MAINIGI K MIELACH F SANCILIO L

Citation: Jf. Contrera et al., A RETROSPECTIVE COMPARISON OF THE RESULTS OF 6-MONTH AND 12-MONTH NON-RODENT TOXICITY STUDIES, Adverse drug reactions and toxicological reviews, 12(1), 1993, pp. 63-76